EA200000040A1 - METHOD OF TREATING DIABETES BY THIAZOLIDINDION AND ALPHA-GLUCOSIDASE INHIBITOR - Google Patents

METHOD OF TREATING DIABETES BY THIAZOLIDINDION AND ALPHA-GLUCOSIDASE INHIBITOR

Info

Publication number
EA200000040A1
EA200000040A1 EA200000040A EA200000040A EA200000040A1 EA 200000040 A1 EA200000040 A1 EA 200000040A1 EA 200000040 A EA200000040 A EA 200000040A EA 200000040 A EA200000040 A EA 200000040A EA 200000040 A1 EA200000040 A1 EA 200000040A1
Authority
EA
Eurasian Patent Office
Prior art keywords
thiazolidindion
alpha
treating diabetes
glucosidase inhibitor
diabetes mellitus
Prior art date
Application number
EA200000040A
Other languages
Russian (ru)
Inventor
Стефен Элистэр Смит
Original Assignee
Смитклайн Бичам Плс
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9712865.6A external-priority patent/GB9712865D0/en
Priority claimed from GBGB9806708.5A external-priority patent/GB9806708D0/en
Application filed by Смитклайн Бичам Плс filed Critical Смитклайн Бичам Плс
Publication of EA200000040A1 publication Critical patent/EA200000040A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Fodder In General (AREA)

Abstract

Описан способ лечения сахарного диабета и состояний, связанных с сахарным диабетом, у млекопитающего, предусматривающий введение эффективного нетоксичного и фармацевтически приемлемого количества сенсибилизатора инсулина и ингибирующего альфа-глюкозидазу антигипергликемического агента млекопитающему, нуждающемуся в этом.Международная заявка была опубликована вместе с отчетом о международном поиске.A method of treating diabetes mellitus and conditions associated with diabetes mellitus in a mammal is described.

EA200000040A 1997-06-18 1998-06-15 METHOD OF TREATING DIABETES BY THIAZOLIDINDION AND ALPHA-GLUCOSIDASE INHIBITOR EA200000040A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9712865.6A GB9712865D0 (en) 1997-06-18 1997-06-18 Novel method of treatment
GBGB9806708.5A GB9806708D0 (en) 1998-03-27 1998-03-27 Novel method
PCT/EP1998/003691 WO1998057635A1 (en) 1997-06-18 1998-06-15 Treatment of diabetes with thiazolidinedione and alpha-glucosidase inhibitor

Publications (1)

Publication Number Publication Date
EA200000040A1 true EA200000040A1 (en) 2000-08-28

Family

ID=26311746

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200000040A EA200000040A1 (en) 1997-06-18 1998-06-15 METHOD OF TREATING DIABETES BY THIAZOLIDINDION AND ALPHA-GLUCOSIDASE INHIBITOR

Country Status (24)

Country Link
EP (1) EP0975343A1 (en)
JP (1) JP2001523271A (en)
KR (1) KR20010013845A (en)
CN (1) CN1274282A (en)
AP (1) AP9901720A0 (en)
AR (2) AR014881A1 (en)
AU (1) AU8799998A (en)
BG (1) BG103966A (en)
BR (1) BR9810186A (en)
CA (1) CA2294134A1 (en)
CO (1) CO4940453A1 (en)
DZ (1) DZ2519A1 (en)
EA (1) EA200000040A1 (en)
IL (1) IL133138A0 (en)
MA (1) MA26510A1 (en)
NO (1) NO996270D0 (en)
NZ (1) NZ501345A (en)
OA (1) OA11631A (en)
PE (1) PE89199A1 (en)
PL (1) PL337577A1 (en)
SK (1) SK179499A3 (en)
TR (1) TR199903072T2 (en)
UY (1) UY25051A1 (en)
WO (1) WO1998057635A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DZ3155A1 (en) 1999-04-23 2000-11-02 Smithkline Beecham Plc New pharmaceutical composition.
JP4590159B2 (en) 2001-04-04 2010-12-01 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド Combination therapy comprising a glucose reabsorption inhibitor and a PPAR modulator
WO2002080935A1 (en) 2001-04-04 2002-10-17 Ortho Mcneil Pharmaceutical, Inc. Combination therapy comprising glucose reabsorption inhibitors and retinoid-x receptor modulators
FR2832930A1 (en) * 2001-12-03 2003-06-06 Lipha PHARMACEUTICAL COMPOSITION COMPRISING AN ALPHA-GLUCOSIDASE INHIBITOR AND A THIAZOLIDINEDIONE DERIVATIVE AND USE THEREOF FOR THE PREPARATION OF MEDICINES FOR TREATING DIABETES
JP2004067575A (en) * 2002-08-06 2004-03-04 Yaizu Suisankagaku Industry Co Ltd Promoter for effect of therapeutic agent for diabetes
CN101121004B (en) * 2006-08-08 2010-07-21 鲁南制药集团股份有限公司 Medicine composition containing insulin intensifier and miglitol
CN101584688B (en) * 2008-05-24 2010-11-10 鲁南制药集团股份有限公司 Medicament composition for treating diabetes and complications of diabetes
CN101584705B (en) * 2008-05-24 2010-10-27 鲁南制药集团股份有限公司 Medicament composition for treating diabetes and complications of diabetes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0601001T3 (en) * 1991-08-26 1997-10-20 Upjohn Co Liquid food product containing 3-guanidinopropionic acid.
US5917052A (en) * 1994-09-28 1999-06-29 Shaman Pharmaceuticals, Inc. Hypoglycemic agent from cryptolepis
TWI238064B (en) * 1995-06-20 2005-08-21 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes

Also Published As

Publication number Publication date
BG103966A (en) 2000-07-31
TR199903072T2 (en) 2000-07-21
JP2001523271A (en) 2001-11-20
MA26510A1 (en) 2004-12-20
CN1274282A (en) 2000-11-22
AU8799998A (en) 1999-01-04
DZ2519A1 (en) 2003-02-01
BR9810186A (en) 2000-08-08
AP9901720A0 (en) 1999-12-31
PE89199A1 (en) 1999-10-23
AR014881A1 (en) 2001-04-11
WO1998057635A1 (en) 1998-12-23
EP0975343A1 (en) 2000-02-02
CA2294134A1 (en) 1998-12-23
IL133138A0 (en) 2001-03-19
AR013352A1 (en) 2000-12-27
PL337577A1 (en) 2000-08-28
NO996270L (en) 1999-12-17
KR20010013845A (en) 2001-02-26
NO996270D0 (en) 1999-12-17
NZ501345A (en) 2001-10-26
SK179499A3 (en) 2000-11-07
OA11631A (en) 2004-11-22
UY25051A1 (en) 2000-09-29
CO4940453A1 (en) 2000-07-24

Similar Documents

Publication Publication Date Title
EA199700170A1 (en) A METHOD OF OBTAINING SOME AZACYCLOHEXAPETIDES
EA199800316A1 (en) SELECTIVE β-ADRENERGIC AGONISTS
AR038437A1 (en) PERMANENT HAIR DYING IN TWO STEPS
DE69625157D1 (en) TREATMENT OF TYPE II DEABETES MELLITUS WITH AMYLINAGONISTS
SV1998000010A (en) COMBINATIONS FOR SULFONYLUREA-GLITAZONE DIABETES.
TR200100773T2 (en) Diabetes treatment method using an aP2 inhibitor and combination
EA200300036A1 (en) COMBINATION OF DIPEPTIDYLPEPIDIDASE INHIBITORS IV AND OTHER ANTI-DIABETIC AGENTS FOR THE TREATMENT OF DIABETES MELLITUS
DE69117163D1 (en) NITROGEN REDUCTION WITH A UREA HYDROLYSATE
FI94265C (en) Method for bleaching lignocellulosic material by oxygen and enzyme treatment
FI971420A0 (en) A method for treating diabetes mellitus using KGF
TR200000755T2 (en) Treatment of anti-oppositional disorder.
EA200000040A1 (en) METHOD OF TREATING DIABETES BY THIAZOLIDINDION AND ALPHA-GLUCOSIDASE INHIBITOR
NO975830L (en) Method of increasing white liquor penetration into wood chips
EA200000140A1 (en) METHOD FOR TREATING DIABETES THIAZOLIDINDIONE, A MEANS FOR STRENGTHENING INSULIN SECRETION, AND ALPHA-GLUCOSIDASE INHIBITOR
FI945695A (en) A method of making pulp fibers with a reduced tendency to fibrillate
PT1067966E (en) OFTHALMIC COMPOSITION UNDERSTANDING A BETA BLOCKER
DE68915968D1 (en) Exhaust treatment method.
ES2176947T3 (en) AUDIO COMPRESSION
FI950014A0 (en) A new cellobiose oxidase, an enzymatic agent and a method for treating pulp
EA200000039A1 (en) TREATMENT OF DIABETES THIAZOLIDINDION AND SULPHONYL URIDE
AR038739A1 (en) A METHOD FOR ACHIEVING A PERMANENT CHANGE OF DESIRED HAIR COLOR USING WATER DYE INTERMEDIARIES TO PH ALCALINO CONTAINING QUATERNARY AMMONIUM COMPOUNDS
ID19925A (en) SOLUTIONS OF HYIPOPHYPTIC NICKELS HAVING CONCENTRATION, LARGER NICKELS
ES2128402T3 (en) A METHOD OF IMPROVING PROCEDURES THAT USE PECTINOUS ENZYMES WITH NOBLE GASES.
DE59808166D1 (en) USE OF 2-METHYL-THIAZOLIDINE-2,4-DICARBONIC ACID AS A MUCOLYTIC
ATE232734T1 (en) USING PVP OR POVIDONE TO REDUCE INTESTINAL SWELLING